Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
famotidine, Quantity: 40 mg
Strides Pharma Science Pty Ltd
Famotidine
Tablet, film coated
Excipient Ingredients: pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400
Oral
30 tablets
(S4) Prescription Only Medicine
Symptomatic relief of heartburn, dyspepsia and indigestion due to gastro-oesophageal reflux in adults over 18 years of age. For the treatment of duodenal ulcer; benign gastric ulcer; Zollinger-Ellison syndrome; prevention of relapses of duodenal ulceration. Short-term (no more than 12 weeks) symptomatic relief of gastro-oesophageal reflux not responsive to conservative measures. Healing of oesophageal erosion or ulceration associated with gastro-oesophageal reflux disease. Prevention of relapses of symptoms and erosions or ulcerations associated with gastro-oesophageal reflux disease.
Visual Identification: A brown, round, biconvex, film coated tablet embossed with '40' on one side and plain on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2012-06-25